-The Business Standard A ray of hope for Indian generic drug makers Gilead Sciences, the California-headquartered biotechnology company, has authorised seven India-based drug makers - Cipla, Ranbaxy, Mylan, Strides Arcolab, Hetero, Cadila Healthcare and Sequent Scientific - to manufacture and sell the generic versions of its hepatitis C medicine, Sovaldi, in 91 developing countries. Earlier in the week, Lupin, the fourth largest Indian drug maker, announced that it will develop and supply...
More »SEARCH RESULT
Total Matching Records found : 4031
Self-regulatory code for doctors, hospitals soon -Rema Nagarajan
-The Times of India A new self regulatory code of conduct for doctors and hospitals, in the process of being formulated, could hold investors and members on the boards of medical establishments responsible for unethical practices in the establishment such as giving cuts to doctors and diagnostic facilities or taking bribes from pharmaceutical Companies. The Indian Medical Association (IMA) and the Association of Hospital Providers of India (AHPI) have constituted a joint...
More »'Decision on GM Tech Should Be Left to Farmers'
-The New Indian Express CHENNAI: Taking out a sharp attack on the anti-GM environmental activists, Professor Dr Shanthu Shantharam of the Iowa State University's Seed Science Centre said that the decision on the usage of GM crops should be left to farmers and not to environmental activists. He was speaking at a seminar on ‘GM Technology - Myth and Reality' organised by the Industrial Economist magazine on Saturday at the CLRI. "Let...
More »Law on sexual harassment at work fosters new business -Namrata Singh
-The Times of India MUMBAI: Enterprising lawyers and gender equality experts have spotted a business opportunity in the new law against sexual harassment of women at work. With the Sexual Harassment of Women at Workplace (Prevention, Prohibition & Redressal) Act, 2013 raising major concerns with respect to corporate liability and a potential threat to reputation on non-compliance, organizations are turning to the pros. This new breed of consultants helps Companies with gender...
More »Jumping a red light may soon cost you Rs 5,000; cellphone use Rs 4,000 -Dipak K Dash
-The Times of India NEW DELHI: If you jump a traffic light, drive on the wrong side of the road, refuse to snap on the seat belt or obstruct emergency vehicles, you may soon have to cough up a fine of Rs 5,000. And if you repeat these offences, the penalty could climb to Rs 10,000 and even Rs 15,000, your licence could be suspended and you may be packed off...
More »
